Recursion Pharmaceuticals, Inc. (RXRX)
USD 4.2
(-12.74%)
USD 4.2
(-12.74%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -344.12 Million USD | 31.02% |
| 2022 | -498.9 Million USD | -82.32% |
| 2021 | -273.63 Million USD | -11.03% |
| 2020 | -246.46 Million USD | -358.84% |
| 2019 | -53.71 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -386.24 Million USD | -55.4% |
| 2024 Q1 | -248.54 Million USD | 27.77% |
| 2023 Q4 | -344.12 Million USD | -2.46% |
| 2023 FY | -344.12 Million USD | 31.02% |
| 2023 Q3 | -335.84 Million USD | 4.85% |
| 2023 Q2 | -352.97 Million USD | 15.98% |
| 2023 Q1 | -420.09 Million USD | 15.8% |
| 2022 Q3 | -402.45 Million USD | -0.57% |
| 2022 Q4 | -498.9 Million USD | -23.97% |
| 2022 Q2 | -400.19 Million USD | 12.2% |
| 2022 Q1 | -455.78 Million USD | -66.57% |
| 2022 FY | -498.9 Million USD | -82.32% |
| 2021 Q2 | -617.25 Million USD | -210.88% |
| 2021 FY | -273.63 Million USD | -11.03% |
| 2021 Q4 | -273.63 Million USD | 29.67% |
| 2021 Q3 | -389.1 Million USD | 36.96% |
| 2021 Q1 | -198.55 Million USD | 19.44% |
| 2020 Q4 | -246.46 Million USD | 0.0% |
| 2020 FY | -246.46 Million USD | -358.84% |
| 2020 Q1 | 69.88 Million USD | 0.0% |
| 2019 FY | -53.71 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -515.166% |
| Alkermes plc | -166.73 Million USD | -106.385% |
| Agenus Inc. | 274.13 Million USD | 225.53% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 118.403% |
| Aptorum Group Limited | 1.35 Million USD | 25458.315% |
| Ardelyx, Inc. | 34.51 Million USD | 1097.114% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 8140.28% |
| Bicycle Therapeutics plc | -481.46 Million USD | 28.526% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 1051.591% |
| ChromaDex Corporation | -24.04 Million USD | -1330.988% |
| Chimerix, Inc. | -25.51 Million USD | -1248.607% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 5038.58% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1353.41% |
| CRISPR Therapeutics AG | -150.84 Million USD | -128.131% |
| Precision BioSciences, Inc. | -85.41 Million USD | -302.908% |
| Dyadic International, Inc. | -6.37 Million USD | -5295.401% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -2059.819% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4589.55% |
| Lantern Pharma Inc. | -21.7 Million USD | -1485.585% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -211.32% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -3928.057% |
| Incyte Corporation | -3.17 Billion USD | 89.162% |
| IO Biotech, Inc. | -140.69 Million USD | -144.582% |
| Jaguar Health, Inc. | 29.39 Million USD | 1270.848% |
| Novavax, Inc. | -298.29 Million USD | -15.364% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 6547.892% |
| Opthea Limited | 28.15 Million USD | 1322.142% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1949.699% |
| ContextLogic Inc. | -232 Million USD | -48.329% |
| MiMedx Group, Inc. | -33.9 Million USD | -915.085% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 3475.419% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -14751.963% |
| NextCure, Inc. | -6.47 Million USD | -5213.015% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -581.42% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -5294.639% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2929.207% |
| Vaxcyte, Inc. | -368.22 Million USD | 6.546% |
| PDS Biotechnology Corporation | -32.7 Million USD | -952.081% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 2091.689% |
| Pharming Group N.V. | 109.8 Million USD | 413.398% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1878.179% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -96.384% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1758.135% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1758.135% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -4746.817% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -5772.423% |
| Acelyrin, Inc. | -216.9 Million USD | -58.653% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -6033.826% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -19860.789% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1092.455% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -4958.415% |
| Senti Biosciences, Inc. | 1.74 Million USD | 19877.241% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -86.409% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -344.312% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -5576.74% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 345020.767% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 54896.815% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -194.007% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -104.552% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 410.385% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -4430.332% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -166.527% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 5091.212% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -41.987% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1865.323% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -8.658% |
| MEI Pharma, Inc. | -3.7 Million USD | -9188.097% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2850.571% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 312.761% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1338.168% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4589.55% |
| Precigen, Inc. | -481 Thousand USD | -71443.451% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2543.889% |
| AlloVir, Inc. | -62.69 Million USD | -448.912% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -518.772% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 658.045% |
| ImmuCell Corporation | 10.99 Million USD | 3231.086% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -123.245% |
| Onconetix, Inc. | 5.33 Million USD | 6554.62% |
| PureTech Health plc | -167.19 Million USD | -105.819% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -1029.757% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1700.0% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -6910.063% |
| Seer, Inc. | -4.24 Million USD | -8016.132% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1331.643% |
| Innoviva, Inc. | 255.56 Million USD | 234.653% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -516.003% |
| ESSA Pharma Inc. | -33.62 Million USD | -923.521% |
| GlycoMimetics, Inc. | -40.98 Million USD | -739.646% |
| GT Biopharma, Inc. | -1.02 Million USD | -33604.603% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -407.685% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 661.771% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -156.658% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2383.574% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -1091.895% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -456697.727% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -1015.041% |
| Aptose Biosciences Inc. | -8.19 Million USD | -4099.268% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -10897.827% |
| Soligenix, Inc. | -4.95 Million USD | -6849.758% |
| Century Therapeutics, Inc. | 847 Thousand USD | 40728.571% |
| Kura Oncology, Inc. | -20.11 Million USD | -1610.528% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -740.844% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -3997.69% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 18990.319% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -10663.966% |
| Autolus Therapeutics plc | -186.59 Million USD | -84.419% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -597.964% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -24.776% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1104.214% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 309.362% |
| GRI Bio, Inc. | -1.79 Million USD | -19081.94% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -3730.816% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -934.742% |
| IGM Biosciences, Inc. | -72.6 Million USD | -373.961% |
| INmune Bio, Inc. | -25.41 Million USD | -1254.232% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 327.971% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -579.295% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2017.768% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -11828.348% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 1005.232% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -735.557% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1179.266% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 191.05% |
| Verastem, Inc. | -37.27 Million USD | -823.129% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3692.836% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -563.538% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -2173.697% |
| Histogen Inc. | -7.48 Million USD | -4496.287% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1492.664% |
| Surrozen, Inc. | -32.66 Million USD | -953.527% |
| Organovo Holdings, Inc. | -1.5 Million USD | -22735.036% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8086.63% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1914.98% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 13254.587% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 8380.173% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -4005.928% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -692.146% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -2260.755% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -8.629% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -47558.643% |
| Apollomics, Inc. | -27.39 Million USD | -1156.156% |
| Amarin Corporation plc | -191.04 Million USD | -80.132% |
| Mesoblast Limited | 55.96 Million USD | 714.913% |
| Turnstone Biologics Corp. | -14.58 Million USD | -2259.6% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1260.604% |
| Synaptogenix, Inc. | -28.66 Million USD | -1100.649% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -36665.385% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 806.156% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -39817.456% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -4636.034% |
| Exelixis, Inc. | -73.05 Million USD | -371.08% |
| Better Therapeutics, Inc. | -860 Thousand USD | -39914.419% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1333.074% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -42.571% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 46851.786% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -4526.482% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 27542.105% |
| Gritstone bio, Inc. | 39.49 Million USD | 971.421% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -309.179% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -12973.925% |
| Avid Bioservices, Inc. | 169.72 Million USD | 302.75% |
| Insmed Incorporated | 721.62 Million USD | 147.688% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3664.41% |
| MediWound Ltd. | -5.32 Million USD | -6366.065% |
| OmniAb, Inc. | 9.2 Million USD | 3839.259% |
| Alector, Inc. | -35.63 Million USD | -865.637% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 500.279% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -6883.036% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2699.32% |
| Zai Lab Limited | -775 Million USD | 55.597% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 201.048% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1498.718% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -317.221% |
| Immunic, Inc. | -45.34 Million USD | -658.985% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -78.104% |
| Veracyte, Inc. | -203.82 Million USD | -68.834% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 153.913% |
| FibroGen, Inc. | 56.76 Million USD | 706.204% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3964.391% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -12072.41% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -16521.553% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 107.497% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -10200.03% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -107.349% |
| TG Therapeutics, Inc. | 17.86 Million USD | 2026.57% |
| Galecto, Inc. | -21.21 Million USD | -1522.002% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1346.811% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 121.927% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1306.195% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2890.562% |
| XBiotech Inc. | -200.02 Million USD | -72.042% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -309.179% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 7699.912% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -875.878% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -345.653% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 6146.811% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -101.933% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -272.533% |
| Vaxxinity, Inc. | 10.13 Million USD | 3496.407% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 146.739% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -3095.936% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -421.748% |
| NexImmune, Inc. | -3.13 Million USD | -10881.596% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -9866.887% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -2177.24% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1169.83% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -3733.801% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -276138.411% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -748.181% |
| Ainos, Inc. | 4.07 Million USD | 8538.697% |
| Pluri Inc. | 22.82 Million USD | 1607.398% |
| Prothena Corporation plc | -608.34 Million USD | 43.433% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -189.774% |
| Celularity Inc. | 65.19 Million USD | 627.879% |
| Rallybio Corporation | -24.1 Million USD | -1327.782% |
| Cue Biopharma, Inc. | -33.81 Million USD | -917.546% |
| MeiraGTx Holdings plc | -40.3 Million USD | -753.863% |
| Omeros Corporation | 331.17 Million USD | 203.91% |
| Humacyte, Inc. | -22.48 Million USD | -1430.392% |
| Immunocore Holdings plc | -358.59 Million USD | 4.035% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1300.301% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -1013.634% |
| Blueprint Medicines Corporation | 702.83 Million USD | 148.962% |
| CalciMedica, Inc. | -5.53 Million USD | -6122.857% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -82.831% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -3269.14% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -759.515% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -934.866% |
| Pulmatrix, Inc. | -10.41 Million USD | -3203.485% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -5657.47% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -802.218% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -208.903% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -474.076% |
| Cytokinetics, Incorporated | 642.37 Million USD | 153.571% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -5809.737% |
| Nutriband Inc. | -251.65 Thousand USD | -136643.266% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -908.599% |
| Vor Biopharma Inc. | 4.3 Million USD | 8102.884% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 94.299% |
| Evogene Ltd. | -19.63 Million USD | -1652.694% |
| ProKidney Corp. | -56.23 Million USD | -511.928% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -607.027% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3625.42% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 125.231% |
| CorMedix Inc. | -43.05 Million USD | -699.312% |
| BioLineRx Ltd. | 7.33 Million USD | 4790.894% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -1152.955% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 845.713% |
| Atai Life Sciences N.V. | -28.55 Million USD | -1105.0% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 15527.91% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1408.257% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 2040.367% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -358.38% |
| MediciNova, Inc. | -50.78 Million USD | -577.629% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -336.678% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1529679.951% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5233.115% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -72.216% |
| Biomea Fusion, Inc. | -166.57 Million USD | -106.594% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -92.275% |
| Mereo BioPharma Group plc | -51.46 Million USD | -568.604% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -262.832% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -17.145% |
| Absci Corporation | -72.59 Million USD | -374.013% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 7636.662% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -46.787% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -265.269% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -259.601% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -780.721% |
| Allakos Inc. | -24.97 Million USD | -1277.874% |
| Imunon, Inc. | -4.21 Million USD | -8066.495% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -2234.31% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -154.154% |
| BioAtla, Inc. | -109.01 Million USD | -215.678% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 46851.786% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -36547.923% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2975.848% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1522.997% |
| XOMA Corporation | -29 Million USD | -1086.634% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1978.043% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3716.815% |
| aTyr Pharma, Inc. | -7.44 Million USD | -4519.734% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -176.103% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -65.314% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -320.798% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -270.971% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -39952.422% |
| Akari Therapeutics, Plc | -3.84 Million USD | -8849.909% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 21304.395% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 124.921% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -28863.375% |
| UroGen Pharma Ltd. | 4.39 Million USD | 7937.03% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 403.244% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 478302.385% |
| Orgenesis Inc. | 21.78 Million USD | 1679.71% |
| Entera Bio Ltd. | -10.62 Million USD | -3137.595% |
| GH Research PLC | -78.07 Million USD | -340.75% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1443.988% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1190.836% |
| Xencor, Inc. | 29.64 Million USD | 1260.855% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -17369.891% |
| Replimune Group, Inc. | 1.41 Million USD | 24471.388% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -140411.539% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -172.213% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -28863.375% |
| Portage Biotech Inc. | -4.98 Million USD | -6808.733% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1529679.951% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -420.438% |
| OncoCyte Corporation | -6.56 Million USD | -5143.395% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 38446.224% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -7453.796% |
| Purple Biotech Ltd. | -14.13 Million USD | -2334.036% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1348.577% |
| scPharmaceuticals Inc. | -6.54 Million USD | -5157.815% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1961.59% |
| HilleVax, Inc. | -165.48 Million USD | -107.949% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -13458.865% |
| Tharimmune, Inc. | -10.93 Million USD | -3046.895% |
| Genprex, Inc. | -6.73 Million USD | -5007.494% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 6.693% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -289.017% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -24462.741% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -10274.724% |
| OKYO Pharma Limited | -826.84 Thousand USD | -41518.774% |
| Savara Inc. | 153 Thousand USD | 225017.647% |
| Curis, Inc. | -23.88 Million USD | -1340.633% |
| Daré Bioscience, Inc. | -5.15 Million USD | -6571.771% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -44245.191% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -5443.235% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 29140.0% |
| BeiGene, Ltd. | -2.25 Billion USD | 84.727% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2889.026% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 43.42% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -85.426% |
| Erasca, Inc. | -37.21 Million USD | -824.667% |
| bluebird bio, Inc. | 108.57 Million USD | 416.958% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -26619.922% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 190.858% |
| DBV Technologies S.A. | -126.98 Million USD | -170.994% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -26619.922% |
| Moderna, Inc. | -2.9 Billion USD | 88.162% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -3224.227% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -3066.397% |
| Molecular Templates, Inc. | 707 Thousand USD | 48773.833% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -996.949% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 199.283% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -319.346% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -275.149% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -966.324% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -901.059% |
| MacroGenics, Inc. | -66.98 Million USD | -413.733% |
| RenovoRx, Inc. | -1.17 Million USD | -29237.084% |
| Adicet Bio, Inc. | -138.78 Million USD | -147.951% |
| Prime Medicine, Inc. | -27.94 Million USD | -1131.609% |
| Aditxt, Inc. | 18.12 Million USD | 1999.046% |
| Adagene Inc. | -87.62 Million USD | -292.713% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8161.432% |
| Quantum-Si incorporated | -118.55 Million USD | -190.26% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 1055.767% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -4504.166% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -609.402% |
| SciSparc Ltd. | -2.06 Million USD | -16564.6% |
| Vericel Corporation | 1.27 Million USD | 27047.847% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2769.685% |
| Minerva Neurosciences, Inc. | 41 Million USD | 939.24% |
| Generation Bio Co. | 31.44 Million USD | 1194.264% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -96.234% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -1012.842% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 395.15% |
| Invivyd, Inc. | -198.47 Million USD | -73.383% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -281.216% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -14252.324% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -386.12% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -4942.11% |
| 2seventy bio, Inc. | 181.71 Million USD | 289.376% |
| ADMA Biologics, Inc. | 90.06 Million USD | 482.08% |
| Clene Inc. | 3.34 Million USD | 10403.114% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3688.784% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1499.758% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5233.115% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1223.57% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 293.692% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -8310.567% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 6979.728% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -6506.335% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -164.093% |
| Evaxion Biotech A/S | 5.28 Million USD | 6609.063% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -205.703% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -162.144% |
| Trevena, Inc. | 2.25 Million USD | 15340.213% |
| Surrozen, Inc. | -32.66 Million USD | -953.527% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -568.072% |
| Cingulate Inc. | 3.08 Million USD | 11263.133% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -11616.854% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 4888.145% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3603.752% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -333.826% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -161.787% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -226.054% |
| Clearmind Medicine Inc. | -3.94 Million USD | -8628.27% |
| Kronos Bio, Inc. | -36.05 Million USD | -854.468% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 3757.392% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 23700.413% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -534.26% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2487.03% |
| ImmunityBio, Inc. | 618.22 Million USD | 155.663% |
| Korro Bio, Inc. | -132.94 Million USD | -158.851% |
| Kineta, Inc. | -4.54 Million USD | -7478.155% |
| BioVie Inc. | -17.73 Million USD | -1840.656% |
| Codexis, Inc. | -43.27 Million USD | -695.276% |
| Celularity Inc. | 65.19 Million USD | 627.879% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -10759.072% |
| Celcuity Inc. | 6.78 Million USD | 5172.95% |
| Virax Biolabs Group Limited | -3.36 Million USD | -10126.738% |
| Cibus, Inc. | -8.07 Million USD | -4160.015% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -8037.243% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 7630.066% |
| IN8bio, Inc. | -16.38 Million USD | -1999.725% |
| Kodiak Sciences Inc. | -103.87 Million USD | -231.287% |
| Annexon, Inc. | -193.75 Million USD | -77.608% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 956000.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1866.535% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -9695.73% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 132.641% |
| Eyenovia, Inc. | 1.25 Million USD | 27439.593% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1379.034% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -10511.286% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -935.053% |
| Arcellx, Inc. | -296.95 Million USD | -15.883% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1664.196% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -484.499% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1560.269% |
| Moolec Science SA | 117.61 Thousand USD | 292682.642% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -796.18% |
| Geron Corporation | 14.76 Million USD | 2431.305% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -807.548% |
| Royalty Pharma plc | 5.65 Billion USD | 106.082% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -143.333% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -4823.496% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -6316.801% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -144.526% |
| Humacyte, Inc. | -22.48 Million USD | -1430.392% |
| Structure Therapeutics Inc. | -124.33 Million USD | -176.763% |
| 89bio, Inc. | -289.05 Million USD | -19.052% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1263.299% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -19200.28% |
| Genelux Corporation | -6.89 Million USD | -4888.027% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -1007.969% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 511.637% |
| Notable Labs, Ltd. | -9.77 Million USD | -3420.09% |
| Liquidia Corporation | -80.17 Million USD | -329.211% |
| Mustang Bio, Inc. | -3.73 Million USD | -9111.028% |
| Immunovant, Inc. | -635.22 Million USD | 45.827% |
| Quantum-Si incorporated | -118.55 Million USD | -190.26% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1859.258% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -8206.155% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 4387.081% |
| Acasti Pharma Inc. | -23 Million USD | -1395.866% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -10119.798% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2017.768% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -149.836% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -10942.491% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1447.877% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1753.218% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -103.289% |
| PepGen Inc. | -60.67 Million USD | -467.206% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1397.754% |
| United Therapeutics Corporation | -507.7 Million USD | 32.219% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1699.247% |
| Solid Biosciences Inc. | -47.75 Million USD | -620.679% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -39817.456% |
| Immuneering Corporation | -54.94 Million USD | -526.331% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8086.63% |
| Silo Pharma, Inc. | -3.52 Million USD | -9664.3% |
| Belite Bio, Inc | -87.27 Million USD | -294.317% |
| XOMA Corporation | -29 Million USD | -1086.634% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -386.759% |
| Bionomics Limited | 227 Million USD | 251.59% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -195.939% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -13485.63% |
| uniQure N.V. | -102.95 Million USD | -234.26% |
| Cassava Sciences, Inc. | -121.13 Million USD | -184.081% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8161.432% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 940.331% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2777.05% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -11021.582% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 324745.283% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -10511.286% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3964.391% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -4540.291% |
| Altimmune, Inc. | -134.48 Million USD | -155.879% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 273.743% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -13485.63% |
| Compugen Ltd. | -12.9 Million USD | -2566.801% |
| Peak Bio, Inc. | 10.34 Million USD | 3428.034% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -121498.587% |
| Benitec Biopharma Inc. | -50.58 Million USD | -580.329% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -229.817% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1851.713% |
| Zura Bio Limited | -99.8 Million USD | -244.793% |
| PolyPid Ltd. | 6.17 Million USD | 5677.374% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 564.28% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1851.713% |
| Instil Bio, Inc. | 75.35 Million USD | 556.652% |
| argenx SE | -2.02 Billion USD | 83.038% |
| Immunome, Inc. | -97.02 Million USD | -254.661% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1429.78% |
| Verona Pharma plc | -220.44 Million USD | -56.106% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -379.662% |
| Shattuck Labs, Inc. | -121.42 Million USD | -183.407% |
| CervoMed Inc. | -7.79 Million USD | -4315.896% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -85.513% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -7769.289% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -161.215% |
| Moolec Science SA | 117.61 Thousand USD | 292682.642% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -14940.536% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 2264.522% |
| AnaptysBio, Inc. | -18.15 Million USD | -1795.896% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1796.0% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -388.944% |
| NeurAxis, Inc. | 145.7 Thousand USD | 236286.685% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 3163.782% |
| Lumos Pharma, Inc. | -28.49 Million USD | -1107.749% |
| Achilles Therapeutics plc | -126.92 Million USD | -171.126% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -379.662% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -52379.527% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1556.527% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 23700.413% |
| Nutriband Inc. | -251.65 Thousand USD | -136643.266% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2512.74% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -4525.323% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 201.154% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1549.859% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 23.096% |
| Palisade Bio, Inc. | -12.06 Million USD | -2752.723% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -145.258% |
| Beam Therapeutics Inc. | -262.72 Million USD | -30.984% |
| Neurogene Inc. | -131.95 Million USD | -160.789% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1677.393% |
| AEON Biopharma, Inc. | -4.88 Million USD | -6951.721% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 8.767% |
| Sesen Bio, Inc. | -112.55 Million USD | -205.744% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -244.606% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -14557.34% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -781.781% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -313.203% |
| Athira Pharma, Inc. | -88.99 Million USD | -286.661% |
| Vaccinex, Inc. | -1.28 Million USD | -26617.702% |
| HCW Biologics Inc. | 2.85 Million USD | 12146.308% |
| XOMA Corporation | -29 Million USD | -1086.634% |
| Nektar Therapeutics | 210.24 Million USD | 263.682% |
| Arvinas, Inc. | -313.8 Million USD | -9.663% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 21304.395% |
| Merus N.V. | -192.88 Million USD | -78.41% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 673.683% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -4859.988% |
| Rezolute, Inc. | -68.16 Million USD | -404.818% |
| Clene Inc. | 3.34 Million USD | 10403.114% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2509.57% |
| BeyondSpring Inc. | -13.75 Million USD | -2401.81% |
| Synlogic, Inc. | -6.68 Million USD | -5047.704% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 30446.032% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -3970.065% |
| Peak Bio, Inc. | 10.34 Million USD | 3428.034% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -317.525% |
| Krystal Biotech, Inc. | -350.23 Million USD | 1.745% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 377.24% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -103.628% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -10799.851% |
| MannKind Corporation | 143.89 Million USD | 339.143% |
| Ikena Oncology, Inc. | -109.15 Million USD | -215.259% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -4445.291% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -939.65% |
| Gossamer Bio, Inc. | 180.35 Million USD | 290.804% |
| CohBar, Inc. | -5.93 Million USD | -5702.388% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -1056.797% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 7636.662% |
| Legend Biotech Corporation | -949.39 Million USD | 63.753% |
| Mural Oncology plc | -255.84 Million USD | -34.506% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1168.21% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -7205.246% |
| Disc Medicine, Inc. | -358.28 Million USD | 3.951% |
| Champions Oncology, Inc. | 4.81 Million USD | 7251.372% |
| REGENXBIO Inc. | 54.76 Million USD | 728.33% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -127871.38% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -127.86% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3718.506% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -326.514% |
| Vaxart, Inc. | -8.24 Million USD | -4075.755% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -585.78% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -170.611% |
| Cellectis S.A. | -43.85 Million USD | -684.686% |
| Longeveron Inc. | -2.9 Million USD | -11733.7% |
| Repare Therapeutics Inc. | -107.85 Million USD | -219.053% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 135.536% |
| Inozyme Pharma, Inc. | 12 Million USD | 2966.744% |
| Revolution Medicines, Inc. | -608.2 Million USD | 43.42% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -27877.561% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -29.801% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -129.306% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -2099.297% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -46403.243% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.402% |
| Denali Therapeutics Inc. | -74.86 Million USD | -359.659% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2769.685% |
| Veru Inc. | 4.77 Million USD | 7299.294% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2959.968% |
| Cingulate Inc. | 3.08 Million USD | 11263.133% |
| Passage Bio, Inc. | 4.58 Million USD | 7605.431% |
| Context Therapeutics Inc. | -14.44 Million USD | -2281.509% |
| Exicure, Inc. | 5.84 Million USD | 5983.467% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -49.375% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -769.659% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 2293.13% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -485.036% |
| Nuvalent, Inc. | -335.38 Million USD | -2.605% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 19941.773% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -362.023% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -3770.911% |
| OmniAb, Inc. | 9.2 Million USD | 3839.259% |
| Anew Medical, Inc. | 1.43 Million USD | 24123.205% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 2200.654% |
| Lipocine Inc. | -4.75 Million USD | -7137.719% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -213.33% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2359.366% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -579.295% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1482.468% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -5020.131% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -422.77% |
| Ocugen, Inc. | -32.52 Million USD | -958.159% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -302.131% |
| Q32 Bio Inc. | -37.94 Million USD | -806.83% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -54696.815% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2443.603% |
| Equillium, Inc. | -22.39 Million USD | -1436.817% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1245.917% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -954.729% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -138707.252% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 356.728% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 10860.6% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 104874.982% |
| Dominari Holdings Inc. | 195 Thousand USD | 176573.846% |
| Edesa Biotech, Inc. | -5.26 Million USD | -6433.698% |
| vTv Therapeutics Inc. | -8.91 Million USD | -3759.19% |
| Bio-Techne Corporation | 267.74 Million USD | 228.526% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -2023.043% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -191.398% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -3995.252% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2620.133% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -40.391% |
| Nkarta, Inc. | 57.29 Million USD | 700.576% |
| BioCardia, Inc. | 212 Thousand USD | 162422.642% |
| Iterum Therapeutics plc | 13.43 Million USD | 2660.828% |